Research paper
Psychomotor slowing, negative symptoms and dopamine receptor availability—an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients

https://doi.org/10.1016/S0920-9964(98)00003-6Get rights and content

Abstract

Anhedonia and psychomotor slowing in schizophrenia have been attributed to a dysfunction of dopaminergic neurotransmission. To differentiate between disease and drug-induced negative symptoms, we examined eight drug-free and eight neuroleptic-treated schizophrenic patients. Positive and negative symptoms and extrapyramidal side effects were assessed using standardized rating scales (PSAS, AMDP, SANS). ‘Reaction time’ and ‘motor speed’ were measured using a computer-aided system and striatal dopamine D2/D3 receptor availability was assessed using [I-123]IBZM SPECT. Psychomotor reaction time, parkinsonism, affective flattening and avolition were increased in treated patients relative to the untreated cohort and were negatively correlated with dopamine D2/D3 receptor availability. Significant positive correlations were found between parkinsonism and affective flattening and between psychomotor slowing and avolition. Positive symptoms were not significantly associated with striatal IBZM binding. These findings support the hypothesis that neuroleptic-induced dopamine D2/D3 blockade in the striatum can mimic certain negative symptoms, such as affective flattening and avolition, and indicates that psychomotor testing may be helpful in differentiating between disease and drug-induced negative symptoms.

References (31)

  • W. Classen et al.

    Psychometrische Untersuchungen von Leistungsdefiziten bei akut schizophren erkrankten Patienten unter besonderer Berücksichtigung des Geschlechts

    Schweiz. Archiv. Neurol. Psychiatr.

    (1991)
  • J. Fishman et al.

    Laterality in schizophrenia. A reaction time study

    Eur. Arch. Psychiatry Clin. Neurosci.

    (1991)
  • W. Guy et al.
  • A. Heinz et al.

    Anhedonia in schizophrenic, depressed, or alcohol-dependent patients—neurobiological correlates

    Pharmacopsychiatry

    (1994)
  • A. Heinz et al.

    Dopamine D2 receptor imaging and neuroleptic drug response

    J. Clin. Psychiatry

    (1996)
  • Cited by (115)

    • Apathy in schizophrenia: A review of neuropsychological and neuroanatomical studies

      2018, Neuropsychologia
      Citation Excerpt :

      In the schizophrenia domain, studies exploring the impact of striatal dopamine D2-like receptions on apathy and also negative symptoms, in general, are contradictory. Some findings point to a negative impact of neuroleptic-induced dopamine D2/D 3 blockade on negative symptoms and apathy (Heinz et al., 1998; de Haan et al., 2000), while another point to the other direction (Fervaha et al., 2016; de Haan et al., 2003). Overall, previous evidence suggests that dopamine plays a role in negative symptoms and apathy.

    • Asymmetries in initiation of aiming movements in schizophrenia

      2018, Neuropsychologia
      Citation Excerpt :

      The novel finding is that in the present case we further show that severity of negative symptoms correlates with magnitude of the delay when the right hand moves from the right starting point. Both negative symptoms and psychomotor slowing in schizophrenia have been attributed to a dysfunction of dopaminergic neurotransmission (Heinz et al., 1998), confirming the possibility that anomalies in dopamine-related hemispheric asymmetries exist in these patients (Downing et al., 1998a). Except for being slower, movement times of SCZ patients essentially followed the pattern observed in controls.

    View all citing articles on Scopus
    View full text